76842-15-4

Usage

Uses

Used in Pharmaceutical Industry:
2-IODO-4-(1-METHYLETHYL)BENZENAMINE is used as a chemical intermediate for the synthesis of various pharmaceuticals, contributing to the development of new medications and therapeutic agents.
Used in Organic Synthesis:
It serves as a versatile building block in organic synthesis, enabling the creation of a wide range of organic compounds for different applications.
Used in Research and Development:
2-IODO-4-(1-METHYLETHYL)BENZENAMINE is utilized in research and development for the exploration and creation of novel pharmaceuticals and agrochemicals, expanding the horizons of chemical and medical innovation.
Used in Agrochemical Industry:
It is also employed as an intermediate in the synthesis of agrochemicals, playing a role in the development of new products for agricultural applications.

Upstream product

• 99-88-7 4-Isopropylaniline 

Downstream Products

• 169883-28-7 2-(4,6-dimethyl-pyrimidin-2-ylsulfanyl)-4-isopropyl-phenylamine 
• 876290-14-1 C₁₃H₁₈IN₃ 
• 1616974-97-0 N-(2-ethynyl-4-isopropylphenyl)-4-methylbenzenesulfonamide 
• 1190199-91-7 2-ethynyl-4-(i-propyl)aniline 
• 1616975-08-6 5-isopropyl-1-tosylindolin-3-one 
• 1628347-67-0 2-{8-isopropyl-11-oxo-5H-dibenzo[b,e][1,4]diazepin-10(11H)-yl}benzonitrile 
• 1415332-44-3 C₁₇H₁₇N 
• 1026554-91-5 N-(4-isopropyl-2-methylsulfanyl-phenyl)-N',N'-bis-(2-methoxy-ethyl)-2-methyl-5-nitro-pyrimidine-4,6-diamine 
• 220953-55-9 2--4-(N-butyl-N-ethylamino)-6-methyl-3-nitropyridine 
• 1027555-90-3 N-(4-isopropyl-2-methylsulfanyl-phenyl)-N'',N''-bis-(2-methoxy-ethyl)-2-methyl-pyrimidine-4,5,6-triamine 

Relevant academic research and scientific papers

Novel phenylcarbazole type organic compounds and an organic electroluminescent device comprising the same

An organic compound represented by chemical formula 1 and an organic light emitting device including the same are provided. Chemical Formula 1.

New indolo[1,2-c]quinazolines for single-crystal field-effect transistor: A united experimental and theoretical studies

Here, we account the synthesis and characterization of a series of symmetrical fused heterocyclic aromatic hydrocarbons (HAHs) with an indolo[1,2-c]quinazoline (IQ) as the core moiety. All the new HAHs IQ series were systematically investigated by using various spectroscopic methods. Furthermore, their photo-physical properties were supported by density functional theory (DFT) and time-dependent density functional theory (TDDFT) studies to support the experimental findings. The tetramethyl-substituted indolo[1,2-c]quinazoline (TMIQ) compound is shown to exhibit the shifted type of π–π stacking interactions, which render this series as a new semiconducting material. Single-crystal-based field-effect transistor devices of TMIQ exhibited efficient charge transport behavior, giving a p-channel field-effect mobility of 0.25 cm2?V?1?s?1 with an on/off ratio of 5 × 105.

Cu(II)-Promoted Cascade Synthesis of Fused Imidazo-Pyridine-Carbonitriles

A Cu(II)-promoted synthesis of an aza-fused N-heterocycle having a benz-imidazopyridine scaffold is developed via an addition-cyclization reaction followed by an Ullmann-type C-N coupling between o-iodoanilines and γ-ketodinitriles. This protocol features a broad substrate scope, giving products in 32-84% yields. The compounds show excellent photoluminescence properties having two absorption maxima in the region between 270-280 and 338-350 nm and emission maxima in the range of 502-533 nm. The HOMO-LUMO energy gap of 3.49-3.57 eV was determined using Gaussian 09 at the B3LYP/6-31G (d, p) basis set level. We also demonstrated a few postsynthetic modifications.

Dispirofluorene-indenofluorene (DSFIF): Synthesis, electrochemical, and optical properties of a promising new family of luminescent materials

A series of new dispiro[fluorene-9′,6,9″,12-indeno[1,2b] fluorenes] (DSFIFs) that combine indenofluorene (IF) and spirobifluorene (SBF) architectural specificities have been prepared. Their anodic oxidations lead to the formation of nonsoluble transparent

AROMATIC AMIDES

This application relates to a compound of formula I (or a pharmaceutically acceptable salt thereof) as defined herein, pharmaceutical compositions thereof, and its use as an inhibitor of factor Xa, as well as a process for its preparation and intermediates therefor.